Literature DB >> 25948650

From Molecular Circuit Dysfunction to Disease: Case Studies in Epilepsy, Traumatic Brain Injury, and Alzheimer's Disease.

Chris G Dulla1, Douglas A Coulter2, Jokubas Ziburkus3.   

Abstract

Complex circuitry with feed-forward and feed-back systems regulate neuronal activity throughout the brain. Cell biological, electrical, and neurotransmitter systems enable neural networks to process and drive the entire spectrum of cognitive, behavioral, and motor functions. Simultaneous orchestration of distinct cells and interconnected neural circuits relies on hundreds, if not thousands, of unique molecular interactions. Even single molecule dysfunctions can be disrupting to neural circuit activity, leading to neurological pathology. Here, we sample our current understanding of how molecular aberrations lead to disruptions in networks using three neurological pathologies as exemplars: epilepsy, traumatic brain injury (TBI), and Alzheimer's disease (AD). Epilepsy provides a window into how total destabilization of network balance can occur. TBI is an abrupt physical disruption that manifests in both acute and chronic neurological deficits. Last, in AD progressive cell loss leads to devastating cognitive consequences. Interestingly, all three of these neurological diseases are interrelated. The goal of this review, therefore, is to identify molecular changes that may lead to network dysfunction, elaborate on how altered network activity and circuit structure can contribute to neurological disease, and suggest common threads that may lie at the heart of molecular circuit dysfunction.
© The Author(s) 2015.

Entities:  

Keywords:  Alzheimer’s disease; circuits; epilepsy; molecular dysfunction; traumatic brain injury

Mesh:

Substances:

Year:  2015        PMID: 25948650      PMCID: PMC4641826          DOI: 10.1177/1073858415585108

Source DB:  PubMed          Journal:  Neuroscientist        ISSN: 1073-8584            Impact factor:   7.519


  160 in total

1.  Physical basis of cognitive alterations in Alzheimer's disease: synapse loss is the major correlate of cognitive impairment.

Authors:  R D Terry; E Masliah; D P Salmon; N Butters; R DeTeresa; R Hill; L A Hansen; R Katzman
Journal:  Ann Neurol       Date:  1991-10       Impact factor: 10.422

2.  Concussion management at the NFL, college, high school, and youth sports levels.

Authors:  Joseph C Maroon; Jeffrey Bost
Journal:  Clin Neurosurg       Date:  2011

3.  Role of extracellular glutamate measured by cerebral microdialysis in severe traumatic brain injury.

Authors:  Roukoz Chamoun; Dima Suki; Shankar P Gopinath; J Clay Goodman; Claudia Robertson
Journal:  J Neurosurg       Date:  2010-09       Impact factor: 5.115

4.  Interneuronal calcium channel abnormalities in posttraumatic epileptogenic neocortex.

Authors:  Leonardo C Faria; Isabel Parada; David A Prince
Journal:  Neurobiol Dis       Date:  2011-12-07       Impact factor: 5.996

5.  Deficient glutamate transport is associated with neurodegeneration in Alzheimer's disease.

Authors:  E Masliah; M Alford; R DeTeresa; M Mallory; L Hansen
Journal:  Ann Neurol       Date:  1996-11       Impact factor: 10.422

6.  Astrocyte uncoupling as a cause of human temporal lobe epilepsy.

Authors:  Peter Bedner; Alexander Dupper; Kerstin Hüttmann; Julia Müller; Michel K Herde; Pavel Dublin; Tushar Deshpande; Johannes Schramm; Ute Häussler; Carola A Haas; Christian Henneberger; Martin Theis; Christian Steinhäuser
Journal:  Brain       Date:  2015-03-12       Impact factor: 13.501

7.  Synaptic NMDA receptor activation stimulates alpha-secretase amyloid precursor protein processing and inhibits amyloid-beta production.

Authors:  Sarah E Hoey; Robert J Williams; Michael S Perkinton
Journal:  J Neurosci       Date:  2009-04-08       Impact factor: 6.167

8.  Amyloid deposition is associated with impaired default network function in older persons without dementia.

Authors:  Reisa A Sperling; Peter S Laviolette; Kelly O'Keefe; Jacqueline O'Brien; Dorene M Rentz; Maija Pihlajamaki; Gad Marshall; Bradley T Hyman; Dennis J Selkoe; Trey Hedden; Randy L Buckner; J Alex Becker; Keith A Johnson
Journal:  Neuron       Date:  2009-07-30       Impact factor: 17.173

9.  GluN2B subunit-containing NMDA receptor antagonists prevent Abeta-mediated synaptic plasticity disruption in vivo.

Authors:  Neng-Wei Hu; Igor Klyubin; Roger Anwyl; Roger Anwy; Michael J Rowan
Journal:  Proc Natl Acad Sci U S A       Date:  2009-11-16       Impact factor: 11.205

Review 10.  Neuroinflammation in Alzheimer's disease.

Authors:  Michael T Heneka; Monica J Carson; Joseph El Khoury; Gary E Landreth; Frederic Brosseron; Douglas L Feinstein; Andreas H Jacobs; Tony Wyss-Coray; Javier Vitorica; Richard M Ransohoff; Karl Herrup; Sally A Frautschy; Bente Finsen; Guy C Brown; Alexei Verkhratsky; Koji Yamanaka; Jari Koistinaho; Eicke Latz; Annett Halle; Gabor C Petzold; Terrence Town; Dave Morgan; Mari L Shinohara; V Hugh Perry; Clive Holmes; Nicolas G Bazan; David J Brooks; Stéphane Hunot; Bertrand Joseph; Nikolaus Deigendesch; Olga Garaschuk; Erik Boddeke; Charles A Dinarello; John C Breitner; Greg M Cole; Douglas T Golenbock; Markus P Kummer
Journal:  Lancet Neurol       Date:  2015-04       Impact factor: 44.182

View more
  13 in total

1.  Neuropathy-associated Fars2 deficiency affects neuronal development and potentiates neuronal apoptosis by impairing mitochondrial function.

Authors:  Xihui Chen; Fangfang Liu; Bowen Li; Yufeng Wang; Lijuan Yuan; Anan Yin; Qi Chen; Weihong Hu; Yan Yao; Mengjie Zhang; YuanMing Wu; Kun Chen
Journal:  Cell Biosci       Date:  2022-07-06       Impact factor: 9.584

Review 2.  Protein biomarkers of epileptogenicity after traumatic brain injury.

Authors:  Denes V Agoston; Alaa Kamnaksh
Journal:  Neurobiol Dis       Date:  2018-07-17       Impact factor: 5.996

3.  Biophysical Modeling Suggests Optimal Drug Combinations for Improving the Efficacy of GABA Agonists after Traumatic Brain Injuries.

Authors:  Shyam Kumar Sudhakar; Thomas J Choi; Omar J Ahmed
Journal:  J Neurotrauma       Date:  2019-01-08       Impact factor: 5.269

4.  Chemogenetics: drug-controlled gene therapies for neural circuit disorders.

Authors:  Scott M Sternson; David Bleakman
Journal:  Cell Gene Ther Insights       Date:  2020-08

5.  The Dynamics of Concussion: Mapping Pathophysiology, Persistence, and Recovery With Causal-Loop Diagramming.

Authors:  Erin S Kenzie; Elle L Parks; Erin D Bigler; David W Wright; Miranda M Lim; James C Chesnutt; Gregory W J Hawryluk; Wayne Gordon; Wayne Wakeland
Journal:  Front Neurol       Date:  2018-04-04       Impact factor: 4.003

Review 6.  Neuroendocrine Abnormalities Following Traumatic Brain Injury: An Important Contributor to Neuropsychiatric Sequelae.

Authors:  Amir M Molaie; Jamie Maguire
Journal:  Front Endocrinol (Lausanne)       Date:  2018-04-25       Impact factor: 5.555

7.  Understanding the Consequences of Repetitive Subconcussive Head Impacts in Sport: Brain Changes and Dampened Motor Control Are Seen After Boxing Practice.

Authors:  Thomas G Di Virgilio; Magdalena Ietswaart; Lindsay Wilson; David I Donaldson; Angus M Hunter
Journal:  Front Hum Neurosci       Date:  2019-09-10       Impact factor: 3.169

Review 8.  Neuroprotective Effects Against POCD by Photobiomodulation: Evidence from Assembly/Disassembly of the Cytoskeleton.

Authors:  Ann D Liebert; Roberta T Chow; Brian T Bicknell; Euahna Varigos
Journal:  J Exp Neurosci       Date:  2016-02-01

Review 9.  Dysregulated Glucose Metabolism as a Therapeutic Target to Reduce Post-traumatic Epilepsy.

Authors:  Jenny B Koenig; Chris G Dulla
Journal:  Front Cell Neurosci       Date:  2018-10-16       Impact factor: 5.505

10.  Corticohippocampal Dysfunction In The OBiden Mouse Model Of Primary Oligodendrogliopathy.

Authors:  Daniel Z Radecki; Elizabeth L Johnson; Ashley K Brown; Nicholas T Meshkin; Shane A Perrine; Alexander Gow
Journal:  Sci Rep       Date:  2018-10-31       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.